Last reviewed · How we verify
Nicorette Inhalator
At a glance
| Generic name | Nicorette Inhalator |
|---|---|
| Sponsor | NJOY, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Cytisine vs Nicotine Replacement Therapy (NA)
- Pharmacist Intervention to Improve Smoking Cessation (NA)
- Lemongrass (Cymbopogon Citratus) on Nicotine Dependence, Cotinine Levels, and Related Biomarkers in Adult Smokers (NA)
- A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV (PHASE4)
- Transcranial Magnetic Stimulation for Nicotine Dependence: An Effectiveness-Implementation Trial (PHASE4)
- Evaluation of Cessation Preferences of Menthol Smoker (NA)
- A Bioavailability Study of Nicotine Delivered by an Electronic Vapour Product (NA)
- Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nicorette Inhalator CI brief — competitive landscape report
- Nicorette Inhalator updates RSS · CI watch RSS
- NJOY, Inc. portfolio CI